Do you ever wonder how life-saving medical treatments get from the minds of researchers to the patients who need them most? Our Technology Transfer team will explain how it works at LA BioMed and share with you some of our most successful innovations. Researchers at LA BioMed are working on everything from treatments for deadly hospital-acquired infections to injectable treatments to eliminate the double chin (that wasn’t the problem we were trying to fix, but that was the result we found)!
Keith Hoffman joined LA BioMed as the Vice President of Business Development & Technology Transfer in June 2016. Before his arrival he was the Vice President of Scientific Affairs at Advera Health Analytics, and has held key positions at a variety of other biomedical companies.